Cargando…
Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy
INTRODUCTION: Targetable alterations such as BRAFV600E mutation and NTRK fusion are enriched in microsatellite instability-high (MSI-H) colorectal cancer (CRC). MSI-H with targetable alterations (MSI-H altered) might present unique opportunities for both targeted therapy and immunotherapy. We system...
Autores principales: | Hua, Hanju, He, Wenguang, Chen, Nan, He, Yinjun, Wu, Guosheng, Ye, Feng, Zhou, Xile, Li, Yandong, Ding, Yongfeng, Zhong, Weixiang, Teng, Lisong, Jiang, Weiqin, Sheng, Qinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870311/ https://www.ncbi.nlm.nih.gov/pubmed/36700211 http://dx.doi.org/10.3389/fimmu.2022.974793 |
Ejemplares similares
-
Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer
por: He, Yinjun, et al.
Publicado: (2023) -
Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer
por: Jiang, Weiqin, et al.
Publicado: (2023) -
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy
por: Jiang, Weiqin, et al.
Publicado: (2021) -
Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
por: Heregger, Ronald, et al.
Publicado: (2023) -
Intestinal Microbiota in Colorectal Adenoma-Carcinoma Sequence
por: Hua, Hanju, et al.
Publicado: (2022)